Yes, it is entirely possible to have a normal A1C while still showing elevated fasting insulin levels when using medications like semaglutide or tirzepatide. In my 30 years of clinical practice and through the The 30-Week Tirzepatide Reset, I've seen this pattern repeatedly in patients aged 45-54 managing diabetes, blood pressure, and stubborn weight. A1C reflects average blood glucose over 2-3 months, but it doesn't reveal the underlying insulin resistance or hyperinsulinemia that drives inflammation, joint pain, and hormonal weight gain.
GLP-1 drugs like tirzepatide dramatically lower post-meal glucose spikes by slowing gastric emptying, boosting insulin secretion only when needed, and suppressing glucagon. This often normalizes A1C within weeks, sometimes dropping it from 7.8 to 6.2 as seen in our clinic cases. Yet fasting insulin can remain high—often 12-25 μU/mL—because these medications don't immediately reverse years of lectin-driven gut damage, toxin accumulation, or hypothalamic signaling errors from ultra-processed foods.
For those embarrassed by obesity, overwhelmed by conflicting advice, or limited by insurance and time, this disconnect explains failed diets and joint pain that makes movement feel impossible. High insulin keeps fat locked in storage, promotes inflammation in knees and hips, and disrupts thyroid and sex hormones. In The 30-Week Tirzepatide Reset, we address this through three 70-day cycles using low-dose tirzepatide cycling—not lifelong dependency. We pair it with a precise lectin-free low-carb plan featuring 221 real-food recipes that eliminate grains and nightshades, reducing gut permeability and lectin inflammation within 14 days.
Our framework combines targeted Drops—Blue for hunger control, Brown for detox support—Japanese-style walking intervals (10 minutes, 3x daily), red light therapy sessions, and chaotic intermittent fasting in maintenance. The 69 Transformation Steps provide a daily roadmap, tracking body composition instead of scale weight to celebrate non-scale victories like better energy, looser clothes, and normalized blood pressure. One patient, John, entered with A1C 7.8, insulin 18, and 40 extra pounds despite diabetes meds. After cycling one box of tirzepatide, following the lectin-free protocol, and adding red light, his insulin fell to 8 μU/mL by week 20 while A1C stabilized at 5.9. He discontinued two medications and maintained results 18 months later.
The core lesson from The 30-Week Tirzepatide Reset is shifting from “I need this drug forever” to restoring your body's natural regulation. By removing modern obstacles like lectins and toxins while giving correct signals through smart cycling and habits, metabolic freedom emerges. Most patients in their 50s see insulin drop 40-60% by week 30 without chasing quick fixes. Focus on labs beyond A1C—fasting insulin, HOMA-IR, CRP—and non-scale victories. This approach works for middle-income families with busy schedules because it uses simple, repeatable real foods and 15-minute daily practices. True healing happens when medication supports the reset, not replaces the lifestyle that keeps weight off naturally.